Literature DB >> 25963299

Immune status of patients with inherited bone marrow failure syndromes.

Neelam Giri1, Blanche P Alter1, Keri Penrose2, Roni T Falk3, Yuanji Pan2, Sharon A Savage1, Marcus Williams2, Troy J Kemp2, Ligia A Pinto2.   

Abstract

Immune function abnormalities have been reported in patients with Fanconi anemia (FA), dyskeratosis congenita (DC) and, rarely, in Shwachman-Diamond syndrome (SDS), and Diamond-Blackfan anemia (DBA), but large systematic studies are lacking. We assessed immunological parameters in 118 patients with these syndromes and 202 unaffected relatives. We compared the results in patients with reference values, and with values in relatives after adjusting for age, sex, corticosteroid treatment, and severe bone marrow failure (BMF). Adult patients (≥18 years) with FA had significantly lower immunoglobulins (IgG, IgA and IgM), total lymphocytes, and CD4 T cells than reference values or adult relatives (P < 0.001); children with FA had normal values. Both children and adults with FA had lower B- and NK cells (P < 0.01) than relatives or reference values. Patients with DC had essentially normal immunoglobulins but lower total lymphocytes than reference values or relatives, and lower T-, B-, and NK-cells; these changes were more marked in children than adults (P < 0.01). Most patients with DBA and SDS had normal immunoglobulins and lymphocytes. Lymphoproliferative responses, serum cytokine levels, including tumor necrosis factor-α and interferon-γ, and cytokine levels in supernatants from phytohemagglutinin-stimulated cultures were similar across patient groups and relatives. Only patients with severe BMF, particularly those with FA and DC, had higher serum G-CSF and Flt3-ligand and lower RANTES levels compared with all other groups or relatives (P < 0.05). Overall, immune function abnormalities were seen mainly in adult patients with FA, which likely reflects their disease-related progression, and in children with DC, which may be a feature of early-onset severe disease phenotype.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25963299      PMCID: PMC4509864          DOI: 10.1002/ajh.24046

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  36 in total

1.  HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood.

Authors:  Ligia A Pinto; Philip E Castle; Richard B Roden; Clayton D Harro; Douglas R Lowy; John T Schiller; Dora Wallace; Marcus Williams; William Kopp; Ian H Frazer; Jay A Berzofsky; Allan Hildesheim
Journal:  Vaccine       Date:  2005-05-20       Impact factor: 3.641

2.  Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.

Authors:  Ligia A Pinto; Raphael Viscidi; Clayton D Harro; Troy J Kemp; Alfonso J García-Piñeres; Matthew Trivett; Franklin Demuth; Douglas R Lowy; John T Schiller; Jay A Berzofsky; Allan Hildesheim
Journal:  Virology       Date:  2006-07-24       Impact factor: 3.616

Review 3.  Immune defects in Fanconi anemia.

Authors:  Sara R Fagerlie; Grover C Bagby
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

Review 4.  Dyskeratosis congenita: multisystemic disorder with special consideration of immunologic aspects. A review of the literature.

Authors:  B Sölder; M Weiss; A Jäger; B H Belohradsky
Journal:  Clin Pediatr (Phila)       Date:  1998-09       Impact factor: 1.168

5.  Immunological phenotype analysis of patients with Fanconi's anaemia and their family members.

Authors:  G Castello; C Gallo; M Napolitano; P A Ascierto
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

6.  Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia.

Authors:  S D Lyman; M Seaberg; R Hanna; J Zappone; K Brasel; J L Abkowitz; J T Prchal; J C Schultz; N T Shahidi
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

7.  Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence.

Authors:  Xiaoling Zhang; Daniel P Sejas; Yuhui Qiu; David A Williams; Qishen Pang
Journal:  J Cell Sci       Date:  2007-04-03       Impact factor: 5.285

8.  Production of interleukin 6, leukemia inhibitory factor and granulocyte-macrophage colony stimulating factor by peripheral blood mononuclear cells in Fanconi's anemia.

Authors:  G P Bagnara; L Bonsi; P Strippoli; U Ramenghi; F Timeus; F Bonifazi; M Bonafè; R Tonelli; G Bubola; M F Brizzi
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

9.  Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita.

Authors:  Matt Knudson; Shashikant Kulkarni; Zuhair K Ballas; Monica Bessler; Frederick Goldman
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

10.  Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha.

Authors:  F Rosselli; J Sanceau; E Gluckman; J Wietzerbin; E Moustacchi
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

View more
  16 in total

Review 1.  Current insights into the diagnosis and treatment of inherited bone marrow failure syndromes in China.

Authors:  Xiaofan Zhu
Journal:  Stem Cell Investig       Date:  2015-08-06

Review 2.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

3.  Clinical features, mutations and treatment of 104 patients of Diamond-Blackfan anemia in China: a single-center retrospective study.

Authors:  Yang Wan; Xiaojuan Chen; Wenbin An; Min Ruan; Jingliao Zhang; Lixian Chang; Ranran Zhang; Shuai Zhu; Yingchi Zhang; Wenyu Yang; Ye Guo; Weiping Yuan; Yao Zou; Yumei Chen; Xiaofan Zhu
Journal:  Int J Hematol       Date:  2016-06-21       Impact factor: 2.490

4.  Impaired immune function in children and adults with Fanconi anemia.

Authors:  Kasiani C Myers; Sharon Sauter; Xue Zhang; Jacob J Bleesing; Stella M Davies; Susanne I Wells; Parinda A Mehta; Ashish Kumar; Daniel Marmer; Rebecca Marsh; Darron Brown; Melinda Butsch Kovacic
Journal:  Pediatr Blood Cancer       Date:  2017-05-30       Impact factor: 3.167

Review 5.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.

Authors:  Andrew C Dietz; Parinda A Mehta; Adrianna Vlachos; Sharon A Savage; Dorine Bresters; Jakub Tolar; Farid Boulad; Jean Hugues Dalle; Carmem Bonfim; Josu de la Fuente; Christine N Duncan; K Scott Baker; Michael A Pulsipher; Jeffrey M Lipton; John E Wagner; Blanche P Alter
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-20       Impact factor: 5.742

6.  Disease progression and clinical outcomes in telomere biology disorders.

Authors:  Marena R Niewisch; Neelam Giri; Lisa J McReynolds; Rotana Alsaggaf; Sonia Bhala; Blanche P Alter; Sharon A Savage
Journal:  Blood       Date:  2022-03-24       Impact factor: 25.476

Review 7.  Fanconi Anemia: A DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging.

Authors:  Robert M Brosh; Marina Bellani; Yie Liu; Michael M Seidman
Journal:  Ageing Res Rev       Date:  2016-05-17       Impact factor: 10.895

Review 8.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

Authors:  Marena R Niewisch; Sharon A Savage
Journal:  Expert Rev Hematol       Date:  2019-09-10       Impact factor: 2.819

Review 9.  Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know.

Authors:  Ruby Khoury; Sharon Sauter; Melinda Butsch Kovacic; Adam S Nelson; Kasiani C Myers; Parinda A Mehta; Stella M Davies; Susanne I Wells
Journal:  Viruses       Date:  2018-01-20       Impact factor: 5.048

10.  Innate immune system activation in zebrafish and cellular models of Diamond Blackfan Anemia.

Authors:  Nadia Danilova; Mark Wilkes; Elena Bibikova; Min-Young Youn; Kathleen M Sakamoto; Shuo Lin
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.